Pricing
  1. JP-listed companies
  2. MIZUHO MEDY CO.,LTD.
  3. Financials
  4. Pretax margin (%)

MIZUHO MEDY CO.,LTD. (4595)

Market cap
¥34.5B
P/E ratio
10.7x
Mizuho Medic develops and manufactures diagnostic test kits for hospitals and consumers, specializing in infectious disease testing including COVID-19 and influenza.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Dec 31, 202542.1-6.97%
Dec 31, 202445.2-6.12%
Dec 31, 202348.2-23.52%
Dec 31, 202263+23.46%
Dec 31, 202151+416.64%
Dec 31, 20209.9-42.89%
Dec 31, 201917.3-8.36%
Dec 31, 201818.9+24.67%
Dec 31, 201715.1+43.09%
Dec 31, 201610.6+16.17%
Dec 31, 20159.1-20.99%
Dec 31, 201411.5+92.38%
Dec 31, 20136-1.98%
Dec 31, 20126.1+166.50%
Dec 31, 20112.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat